War on Drugs: Difference between revisions
mNo edit summary |
mNo edit summary |
||
Line 20: | Line 20: | ||
|- | |- | ||
| colspan="1" rowspan="1" |c. 1953 | | colspan="1" rowspan="1" |c. 1953 | ||
| colspan="1" rowspan="1" |ACNP Founding president Joel Elkes | | colspan="1" rowspan="1" |American College of Neuropsychopharmacology (ACNP) Founding president Joel Elkes publishes on LSD after openly self-experimenting with it | ||
| colspan="1" rowspan="1" |Bradley ''et al'', 1953<ref>Bradley PB, Elkes C, Elkes J (1953). On some effects of lysergic acid diethylamide (L.S.D. 25) in normal volunteers. J Physiol 121. [PubMed] [Google Scholar] [Ref list]</ref>; Roberts, 2008<ref>Roberts A (2008) Albion Dreaming: A Popular History of LSD in Britain. Marshall Cavendish: London.</ref> | | colspan="1" rowspan="1" |Bradley ''et al'', 1953<ref>Bradley PB, Elkes C, Elkes J (1953). On some effects of lysergic acid diethylamide (L.S.D. 25) in normal volunteers. J Physiol 121. [PubMed] [Google Scholar] [Ref list]</ref>; Roberts, 2008<ref>Roberts A (2008) Albion Dreaming: A Popular History of LSD in Britain. Marshall Cavendish: London.</ref> | ||
|- | |- |
Revision as of 08:03, 25 September 2022
Through the 1950s and 1960s, more than 1,000 research papers were written about LSD, psilocybin, and other psychedelic drugs. Some 40,000 subjects were given these mind-expanding agents, and great progress was made in the understanding of how they might help people suffering from depression, alcoholism, and the psychospiritual distress. However, a series of unfortunate events occurred which mired psychedelics, started a War on Drugs which eventually led to the US government outlawing the substance which then led to a UN resolution which criminalised them worldwide.
To understand this progression better, the table below charts out notable landmarks leading up to criminalisation.
Year | Landmark | References |
---|---|---|
1943 | LSD’s psychoactive effects discovered by Albert Hofmann (16th and 19th April) | Hofmann, 1980[1] |
1947 | Werner Stoll publishes first paper on psychological effects of LSD in humans | Stoll, 1947[2] |
1950 | First English language publication on LSD | Busch and Johnson, 1950[3] |
c. 1953 | American College of Neuropsychopharmacology (ACNP) Founding president Joel Elkes publishes on LSD after openly self-experimenting with it | Bradley et al, 1953[4]; Roberts, 2008[5] |
1954 | Aldous Huxley’s ‘The Doors of Perception’ published: documents mescaline self-experiment | Huxley, 1954[6] |
1956 | Term ‘psychedelic’ coined by Humphrey Osmond in communication with Aldous Huxley | Huxley, 1980[7] |
1957 | Term ‘magic mushrooms’ coined by LIFE magazine | Wasson, 1957[8] |
1958 | Identification of psilocybin in magic mushrooms by Albert Hofmann | Hofmann et al, 1958[9] |
1959 | Closed conference held in Princeton on ‘the use of LSD in psychotherapy’, Jonathan Cole attends, an early ACNP president | Abramson, 1959[10] |
1960 | First major European conference on psychedelics; Sidney Cohen publishes positive meta-analysis on LSD safety | Passie, 1996[11]; Cohen, 1960[12] |
1961 | Jonathan Cole (ACNP president 1965-66) expresses ‘very mixed feelings on psychedelic research’ as critical commentaries emerge | Mangini, 1998[13] |
1962 | The Marsh Chapel or ‘Good Friday’ experiment conducted at Harvard under Timothy Leary’s supervision but without institutional approval | Pahnke, 1966[14]; Mangini, 1998[15] |
1963 | Leary dismissed from Harvard; Aldous Huxley and JFK die (both on 22nd November) | Stevens, 1987[16] |
1964 | Cole takes ‘sober look’ at psychedelics in JAMA; discussions on LSD take center stage at 1964 APA meeting; Ken Kesey travels across US taking LSD with ‘Merry Pranksters’ | Mangini, 1998[13]; Cole and Katz, 1964[17]; Stevens, 1987[16] |
1965 | Sandoz stop manufacture of LSD and psilocybin | Stevens, 1987[16] |
1966 | Prohibition of psychedelics and curtailment of research begins in US; Senator Robert Kennedy formally questions this move | Stevens, 1987[16]; Lee and Shlain, 1992[18] |
1967 | Timothy Leary declares ‘turn on, tune in and drop out’ at festival in Golden Gate Park | Stevens, 1987[16] |
1970 | President Nixon signs Controlled Substances Act, LSD and psilocybin made Schedule 1 | Stevens, 1987[16]; Lee and Shlain, 1992[19] |
Just before criminalisation psychedelic drugs, along with marijuana, were increasing linked in the public imagination with the 1960s counterculture, the antiwar movement, the crusade for sexual liberation, and the rising popularity of Eastern mysticism, yoga, and meditation. President Richard Nixon proclamation of Timothy Leary as “the most dangerous man in America.” led to the crackdown on psychoactive drugs becoming part of a broader political reaction against the liberation movements on the 1960s. Leary’s mantra of “turn on, tune in, drop out” was seen as a direct threat to the corporate establishment and the consumerist, materialist mindset.
In addition, this moratorium was further hastened by tighter regulation of pharmaceutical research, the failure of controlled clinical trials to live up to the claims of psychedelic advocates, and the pharmaceutical industry's lack of interest in funding clinical trials.[20]
- ↑ LSD: My Problem Child. McGraw-Hill: New York. Hofmann A (1980)
- ↑ Lysergsäure-diäthyl-amid, ein Phantastikum aus der Mutterkorngruppe. Stoll W (1947). Schweiz Arch Neur 60: 1–2.
- ↑ Busch AK, Johnson WC (1950). L.S.D. 25 as an aid in psychotherapy; preliminary report of a new drug. Dis Nerv Syst 11: 241–243. [PubMed] [Google Scholar] [Ref list]
- ↑ Bradley PB, Elkes C, Elkes J (1953). On some effects of lysergic acid diethylamide (L.S.D. 25) in normal volunteers. J Physiol 121. [PubMed] [Google Scholar] [Ref list]
- ↑ Roberts A (2008) Albion Dreaming: A Popular History of LSD in Britain. Marshall Cavendish: London.
- ↑ Huxley A (1954) The Doors of Perception. On the author's sensations under the influence of the drug mescalin.. Chatto & Windus: London.
- ↑ Huxley A (1980) Moksha: Writings on Psychedelics and the Visionary Experience. Chatto and Windus: London. pp 1931–1963.
- ↑ Wasson RG (1957). Seeking the magic mushroom. LIFE Magazine 49: 100–102.
- ↑ Hofmann A, Heim R, Brack A, Kobel H (1958). Psilocybin, a psychotropic substance from the Mexican mushroom Psilicybe mexicana Heim. Experientia 14: 107–109.
- ↑ Abramson A (1959) The Use of LSD in Psychotherapy. Josiah Macy, Jr. Foundation: New York.
- ↑ Passie T (1996). Hanscarl leuner—pioneer of hallucinogen research and psycholytic therapy. Maps Newslett 7: 46–49.
- ↑ Cohen S (1960). Lysergic acid diethylamide: side effects and complications. J Nerv Ment Dis 130.1: 30–40.
- ↑ 13.0 13.1 Mangini M (1998). Treatment of alcoholism using psychedelic drugs: a review of the program of research. J Psychoactive Drugs 30: 381–418.
- ↑ Pahnke WN (1966). Drugs and mysticism. Int J Parapsychol 8: 295–315.
- ↑ Mangini M (1998). Treatment of alcoholism using psychedelic drugs: a review of the program of research. J Psychoactive Drugs 30: 381–418.
- ↑ 16.0 16.1 16.2 16.3 16.4 16.5 Stevens J (1987) Storming Heaven: LSD and the American Dream. Paladin: London.
- ↑ Cole JO, Katz MM (1964). The psychotomimetic drugs: an overview. JAMA 187: 758–761.
- ↑ Lee MA, Shlain B (1992) Acid Dreams: The Complete Social History of LSD: The CIA, The Sixties, and Beyond. In: Rev. Evergreen (ed). Grove Weidenfeld: New York.
- ↑ Lee MA, Shlain B (1992) Acid Dreams: The Complete Social History of LSD: The CIA, The Sixties, and Beyond. In: Rev. Evergreen (ed). Grove Weidenfeld: New York.
- ↑ Why was early therapeutic research on psychedelic drugs abandoned? Wayne Hall. Published online by Cambridge University Press: 21 October 2021. Accessed on 25 Sept 2022 via https://www.cambridge.org/core/journals/psychological-medicine/article/abs/why-was-early-therapeutic-research-on-psychedelic-drugs-abandoned/59F93D11DE21F420465559BBEB99CC14